Today’s Hot List: XBiotech, Inc. (NASDAQ:XBIT), Trillium Therapeutics Inc. (NASDAQ:TRIL), Health Care REIT, Inc. (NYSE:HCN), Conatus Pharmaceuticals (NASDAQ:CNAT), BioMed Realty Trust (NYSE:BMR)

XBiotech, Inc. (NASDAQ:XBIT) belongs to Healthcare sector. Its weekly performance is -18.08%. On last trading day company shares ended up $15.27. XBiotech, Inc. (NASDAQ:XBIT) distance from 50-day simple moving average (SMA50) is -21.51%.On 7 July, XBiotech, Inc. (NASDAQ:XBIT) announced publication of clinical results from an open label pilot study for its antibody therapy for treatment of Type 2 diabetes. The results are now available online as an “Article in Press” in the Journal of Diabetes and its Complications. The findings point towards a groundbreaking therapy for Type 2 diabetes by treating the disease rather than its symptoms. The Company has developed a True Human monoclonal antibody therapy derived from an individual with natural immunity to the body’s own inflammatory process that can disrupt pancreas function and limit insulin action.

Trillium Therapeutics Inc. (NASDAQ:TRIL) shares moved up 2.91% in last trading session and ended the day at $21.90. Trillium Therapeutics Inc. (NASDAQ:TRIL) quarterly performance is -18.48%. On 10 July, Trillium Therapeutics Inc. (NASDAQ:TRIL) said that, it provides an overview of the Trillium Therapeutics Inc.’s pharmaceutical research and development focus.

On 14 July, Health Care REIT, Inc. (NYSE:HCN) shares fell -0.48% and was closed at $68.13. HCN EPS growth in last 5 year was 1.10%. Health Care REIT, Inc. (NYSE:HCN) year to date (YTD) performance is -7.98%. Health Care REIT, Inc. (NYSE:HCN) notified holders of its 3.00% Convertible Senior Notes due 2029 (the “Notes”) that they continue to be entitled to convert all or a portion of their Notes into cash and, if applicable, shares of the company’s common stock (the “Conversion Option”) through the close of business on September 30, 2015.

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) belongs to Healthcare sector. Its weekly performance is 6.50%. On last trading day company shares ended up $5.24. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) distance from 50-day simple moving average (SMA50) is -5.43%. Zacks upgraded shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) from a sell rating to a hold rating in a research report released on Wednesday morning.

BioMed Realty Trust Inc. (NYSE:BMR) shares moved up 0.45% in last trading session and ended the day at $20.11. BMR Gross Margin is 67.70% and its return on assets is 3.10%. BioMed Realty Trust Inc. (NYSE:BMR) quarterly performance is -3.95%.BioMed Realty Trust Inc. (NYSE:BMR) announced that its board of directors has declared a second quarter 2015 dividend of $0.26 per share of common stock. The dividend is equivalent to an annualized dividend of $1.04 per common share.The common stock dividend is payable on July 15, 2015 to stockholders of record at the close of business on June 30, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *